Osamah Hamouda

Osamah Hamouda

Auto-generated profile, based on publicly available information

Osamah Hamouda

Department for Infectious Disease Epidemiology, Division for HIV/AIDS, STI and Blood-borne Infections, Robert Koch Institute, Berlin, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2013 in Retrovirology
Verified
Journal Article
Open access
PDF file
AAAna Abecasis
Ana Abecasis
AWannemarie M.J. wensing
annemarie M.J. wensing
Dimitrios ParaskevisDimitrios Paraskevis
Dimitrios Paraskevis
JVJurgen Vercauteren
Jurgen Vercauteren
KTKristof Theys
Kristof Theys
AVAnne-Mieke Vandamme
Anne-Mieke Vandamme
Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes.

20 May 2009 in Retrovirology
Verified
Journal Article
Open access
PDF file
TPThe Spread Programme
The Spread Programme
Dimitrios ParaskevisDimitrios Paraskevis
Dimitrios Paraskevis
OPOliver Pybus
Oliver Pybus
GMGkikas Magiorkinis
Gkikas Magiorkinis
AHAngelos Hatzakis
Angelos Hatzakis
AVAnne-Mieke Vandamme
Anne-Mieke Vandamme
The prevalence and the origin of HIV-1 subtype B, the most prevalent circulating clade among the long-term residents in Europe, have been studied extensively. However the spatial diffusion of the epidemic from the perspective of the virus has not previously been traced. In the current study we inferred the migration history of HIV-1 subtype B by way of a phylogeography of viral sequences sampled from 16 European countries and Israel. Migration events were inferred from viral phylogenies by character reconstruction using parsimony. With regard to the spatial dispersal of the HIV subtype B sequences across viral phylogenies, in most of the countries in Europe the epidemic was introduced by multiple sources and subsequently spread within local networks. Poland provides an exception where most of the infections were the result of a single point introduction. According to the significant migratory pathways, we show that there are considerable differences across Europe. Specifically, Greece, Portugal, Serbia and Spain, provide sources shedding HIV-1; Austria, Belgium and Luxembourg, on the other hand, are migratory targets, while for Denmark, Germany, Italy, Israel, Norway, the Netherlands, Sweden, Switzerland and the UK we inferred significant bidirectional migration. For Poland no significant migratory pathways were inferred. Subtype B phylogeographies provide a new insight about the geographical distribution of viral lineages, as well as the significant pathways of virus dispersal across Europe, suggesting that intervention strategies should also address tourists, travellers and migrants.

21 July 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DFDineke Frentz
Dineke Frentz
DVDavid Van De Vijver
David Van De Vijver
AAAna Abecasis
Ana Abecasis
JAJan Albert
Jan Albert
OHOsamah Hamouda
Osamah Hamouda
CBCharles AB Boucher
Charles AB Boucher
One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program.

3 April 2013 in Retrovirology
Verified
Journal Article
Open access
PDF file
DFDineke Frentz
Dineke Frentz
AWannemarie M.J. wensing
annemarie M.J. wensing
JAJan Albert
Jan Albert
Dimitrios ParaskevisDimitrios Paraskevis
Dimitrios Paraskevis
AAAna Abecasis
Ana Abecasis
SPSpread Programme
Spread Programme
Background: International travel plays a role in the spread of HIV-1 across Europe. It is, however, not known whether international travel is more important for spread of the epidemic as compared to endogenous infections within single countries. In this study, phylogenetic associations among HIV of newly diagnosed patients were determined across Europe. Results: Data came from the SPREAD programme which collects samples of newly diagnosed patients that are representative for national HIV epidemics. 4260 pol sequences from 25 European countries and Israel collected in 2002–2007 were included. We identified 457 clusters including 1330 persons (31.2% of all patients). The cluster size ranged between 2 and 28. A number of 987 patients (74.2%) were part of a cluster that consisted only of patients originating from the same country. In addition, 135 patients (10.2%) were in a cluster including only individuals from neighboring countries. Finally, 208 patients (15.6%) clustered with individuals from countries without a common border. Clustering with patients from the same country was less prevalent in patients being infected with B subtype (P-value <0.0001), in men who have sex with men (P-value <0.0001), and in recently infected patients (P-value =0.045). Conclusions: Our findings indicate that the transmission of HIV-1 in Europe is predominantly occurring between patients from the same country. This could have implications for HIV-1 transmission prevention programmes. Because infections through travelling between countries is not frequently observed it is important to have good surveillance of the national HIV-1 epidemics.

19 March 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TGthe German ClinSurv HIV Study Group
the German ClinSurv HIV Study Group
BKBasel Karo
Basel Karo
WHWalter Haas
Walter Haas
CKChristian Kollan
Christian Kollan
BGBarbara Gunsenheimer-Bartmeyer
Barbara Gunsenheimer-Bartmeyer
LFLena Fiebig
Lena Fiebig
Tuberculosis (TB) still presents a leading cause of morbidity and mortality among people living with HIV/AIDS (PLWHA), including those on antiretroviral therapy. In this study, we aimed to determine the long-term incidence density rate (IDR) of TB and risk factors among PLWHA in relation to combination antiretroviral therapy (cART)-status.

11 June 2009 in BMC Public Health
Verified
Journal Article
Open access
PDF file
UMUlrich Marcus
Ulrich Marcus
ASAxel J. Schmidt
Axel J. Schmidt
OHOsamah Hamouda
Osamah Hamouda
MBMichael Bochow
Michael Bochow
Measurement of prevalence and incidence of infections in a hard to reach population like men who have sex with men (MSM) is hampered by its unknown size and regional distribution. Population-based surveys have recently been used to estimate the total number of MSM, but these surveys are usually not large enough to measure regional differences in the proportion of MSM in the population. We explored the use of the proportional regional distribution of participants of large internet-based surveys among MSM from Germany to estimate the regional distribution of MSM in Germany.